Corporate Strategy and Business Development

Experience supporting internal strategic planning and corporate development initiatives across global markets

Commercial Opportunity Assessment

Articulating an asset’s value proposition to investors and pharmas by defining its differentiation, strategic positioning, and commercial potential

Valuation

Generating the valuation of an asset, platform, or company by triangulating risk-adjusted net present value (rNPV) and transaction / market comparables

Indication / Pipeline Prioritization

Evaluating information segments (e.g., market size, competition, investor/pharma sentiment) across prospective indications of an asset/platform to inform R&D strategy or corporate development

Search & Evaluation and Buy-Side Diligence

Identifying, prioritizing, and diligencing opportunities to bolster client portfolios utilizing robust scientific and commercial expertise as well as perspectives from the investor community

Sell-Side Transaction Advisory

Securing non-dilutive capital and pharma partners’ resources by accessing our global network of buyers and leveraging experience from our $8B+ deal sheet